Navigation Links
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call
Date:7/1/2008

PRINCETON, N.J., July 1 /PRNewswire-FirstCall/ -- In conjunction with its second quarter 2008 earnings release (expected to be issued after market close on July 30), Covance Inc. (NYSE: CVD) is pleased to invite you to listen to its quarterly investor conference call that will be broadcast live over the Internet on Thursday, July 31, 2008 at 9:00 a.m. ET.

What: Covance Second Quarter 2008 Earnings Webcast and Slide

Presentation

When: July 31, 2008, 9:00 a.m. ET*

Where: http://www.covance.com

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 8,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

*If you are unable to participate during the live webcast, the event will be archived on the web site http://www.covance.com for 14 days.


'/>"/>
SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Covance to Present at the William Blair Growth Stock Conference
2. Covance Elects Joseph C. Scodari to Companys Board of Directors
3. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call
4. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
5. Covance to Present at Raymond James 29th Annual Institutional Investors Conference
6. Covance to Present at UBS Global Healthcare Services Conference
7. Covance to Present at 26th Annual JPMorgan Healthcare Conference
8. Wendel Barr Appointed Chief Operating Officer of Covance
9. Covance and Care Partner on Rwanda Early Childhood Development Initiative
10. eResearchTechnology, Inc. to Announce Agreement to Acquire the Centralized ECG Business of Covance
11. eResearchTechnology (eRT) Agrees to Acquire the Centralized ECG Business of Covance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are ... Code Talker Award, an essay contest in which patients and their families pay tribute ... presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: